Synonyms: PF-07304814 | PF07304814
Compound class:
Synthetic organic
Comment: PF-07304814 is a SARS-CoV-2 3CL protease (Mpro) inhibitor from Pfizer. The structure of PF-07304814 is identical to that of the INN lufotrelvir (from proposed list 125, July 2021). PF-07304814's phosphate group (which improves solubility) is cleaved in vitro to release the active antiviral PF-00835231 [1-2]. PF-00835231 was originally developed as a SARS-CoV Mpro inhibitor in response to the 2002-2003 outbreak [3]. Like remdesivir, PF-07304814 is administered by intravenous infusion.
|
|
Classification | |
Compound class | Synthetic organic |
Is prodrug? | Yes |
Active form | PF-00835231 |
IUPAC Name |
[(3S)-3-[(2S)-2-[(4-methoxy-1H-indol-2-yl)formamido]-4-methylpentanamido]-2-oxo-4-[(3S)-2-oxopyrrolidin-3-yl]butoxy]phosphonic acid |
International Nonproprietary Names | |
INN number | INN |
12095 | lufotrelvir |
Synonyms |
PF-07304814 | PF07304814 |
Database Links | |
GtoPdb PubChem SID | 434122309 |
PubChem CID | 154699467 |
RCSB PDB Ligand | 80I, 80I |
Search Google for chemical match using the InChIKey | FQKALOFOWPDTED-WBAXXEDZSA-N |
Search Google for chemicals with the same backbone | FQKALOFOWPDTED |
Search PubMed clinical trials | lufotrelvir |
Search PubMed titles | lufotrelvir |
Search PubMed titles/abstracts | lufotrelvir |
UniChem Compound Search for chemical match using the InChIKey | FQKALOFOWPDTED-WBAXXEDZSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | FQKALOFOWPDTED-WBAXXEDZSA-N |